Online citations, reference lists, and bibliographies.
← Back to Search

Diagnostics And High Throughput Screening

A. D. Campo, I. Bruce
Published 2005 · Computer Science

Cite This
Download PDF
Analyze on Scholarcy
Share
I. High Throughput Screening and Nanotechnology Tools for Biomedicine A. Definition of High Throughput Screening B. HTPS Architectures C. Nanotechnology and HTPS D. Principal Applications of HTPS in Biomedicine II. Flat Surface Microarrays A. DNA Microarrays B. Protein Arrays C. Affinity Capture Arrays D. Carbohydrate Arrays E. Cell Arrays F. Tissue Microarrays III. Nonpositional HTPS Platforms A. Automated Ligand Identification System B. Fiberoptic Arrays C. Suspension Arrays IV. Microfluidics, Microelectromechanical Systems, and Micro Total Analysis Systems V. New Trends in Detection Systems A. New Labeling Systems: Nanoparticles and Quantum Dots B. Label-Free Detection Systems VI. Bioinformatics VII. Applications of HTPS in Biomedicine A. Genetic Diseases
This paper references
10.1097/00002281-200311000-00004
New molecular research technologies in the study of muscle disease
E. Hoffman (2003)
10.1016/S1367-5931(02)00323-X
Microchip-based high-throughput screening analysis of combinatorial libraries.
J. Khandurina (2002)
10.1152/AJPGI.00519.2001
Cutting-edge technology. I. Global gene expression profiling using DNA microarrays.
M. Arcellana‐Panlilio (2002)
10.1063/1.1576915
Microcantilever resonance-based DNA detection with nanoparticle probes
Ming Su (2003)
10.1093/JN/131.5.1605S
Molecular approaches to studying nutrient metabolism and function: an array of possibilities.
K. Hirschi (2001)
10.1097/00001703-200302000-00008
New technologies for the identification of markers for early detection of ovarian cancer
C. Bandera (2003)
10.1093/CLINCHEM/47.3.393
Miniaturization technologies for molecular diagnostics.
R. Mcglennen (2001)
10.1007/s00253-003-1515-0
Micro total analysis system (μ-TAS) in biotechnology
S. Lee (2003)
10.1002/HEP.1840360603
Gene array analysis and the liver
N. Shackel (2002)
10.1016/J.PT.2003.08.002
DNA microarrays in parasitology: strengths and limitations.
J. Boothroyd (2003)
10.1016/S0167-7799(01)01846-7
Protein therapeutics: promises and challenges for the 21st century.
Z. Weng (2002)
Nanotechnologies and microchips in genetic diseases.
Massimo Carella (2003)
10.1016/S0378-4274(02)00500-3
Toxicogenomics: challenges and opportunities.
G. Orphanides (2003)
10.1016/J.CRVI.2003.09.009
From the messenger RNA saga to the transcriptome era.
F. Gros (2003)
Tissue microarray: a new technology for amplification of tissue resources.
D. Rimm (2001)
Functional genomics and gene microarrays--the use in research and clinical medicine.
L. Joos (2003)
10.1016/S0736-5748(02)00041-2
Microarray analysis of normal and dystrophic skeletal muscle
J. N. Haslett (2002)
10.1002/ANIE.200353203
Bioactive protein nanoarrays on nickel oxide surfaces formed by dip-pen nanolithography.
J. Nam (2004)
10.1097/00062752-200107000-00012
Genomic approaches to the pathogenesis of hematologic malignancy
T. Golub (2001)
10.5483/BMBREP.2004.37.1.001
Quantitative analysis of nucleic acids--the last few years of progress.
Chunming Ding (2004)
10.1007/S00216-003-2088-6
Protein microarrays: new tools for pharmaceutical development
K. D. Kumble (2003)
10.1034/J.1399-0039.2003.00109.X
Current and potential uses for DNA microarrays in transplantation medicine: lessons from other disciplines.
A. Boussioutas (2003)
10.1016/S0167-7799(01)01898-4
Novel miniaturized systems in high-throughput screening.
B. Battersby (2002)
10.1016/S0022-1759(02)00137-0
The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications.
R. Frank (2002)
10.1023/B:ECTX.0000003033.09923.A8
Gene Expression Profiling in Ecotoxicology
T. Snell (2003)
10.1016/S0021-9673(01)01451-0
Bioanalysis in microfluidic devices.
J. Khandurina (2002)
10.1016/S0955-0674(02)00315-0
"Omic" approaches for unraveling signaling networks.
H. Zhu (2002)
10.1146/ANNUREV.BIOENG.1.1.265
Nucleic acid biotechnology.
C. Roth (1999)
10.1016/S1359-6446(03)02773-9
Developments in microarray technologies.
D. Howbrook (2004)
10.1002/ijc.10867
Breast cancer revisited using DNA array‐based gene expression profiling
F. Bertucci (2003)
10.1043/0003-9985(2002)126<0255:TPE>2.0.CO;2
The postgenomic era: implications for the clinical laboratory.
F. Kiechle (2002)
10.1023/A:1020948603490
Expression Profiling with Oligonucleotide Arrays: Technologies and Applications for Neurobiology
T. Sendera (2004)
10.1016/S0006-3223(00)01080-5
The “chip” as a specific genetic tool
S. Watson (2000)
10.1016/S0167-7799(03)00002-7
Oligosaccharide microarrays for glycomics.
J. Hirabayashi (2003)
10.1016/S1368-8375(02)00162-8
Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management.
J. Nagpal (2003)
10.1200/JCO.2002.20.7.1932
DNA microarrays in clinical oncology.
S. Ramaswamy (2002)
10.1016/J.YGENO.2003.11.004
ChIP-chip: considerations for the design, analysis, and application of genome-wide chromatin immunoprecipitation experiments.
M. Buck (2004)
10.1146/ANNUREV.PHYSIOL.65.092101.142716
Application of microarray technology in environmental and comparative physiology.
A. Gracey (2003)
10.1002/jcb.10427
Nanobiosensors: Probing the sanctuary of individual living cells
T. Vo-Dinh (2002)
10.1016/S1359-6446(02)02386-3
Applications of transfected cell microarrays in high-throughput drug discovery.
S. N. Bailey (2002)
10.1023/A:1021425004264
Application of DNA Microarrays in Pharmacogenomics and Toxicogenomics
K. Chin (2004)
10.1016/S1367-5931(02)00326-5
From combinatorial chemistry to chemical microarray.
K. Lam (2002)
10.1016/S1471-1931(02)00200-8
Protein chips: from concept to practice.
Young-Sam Lee (2002)
10.2144/03353DD01
Integration of genomic technologies for accelerated cancer drug development.
M. Basik (2003)
10.1046/j.1462-5822.2001.00152.x
Microarray analysis of pathogens and their interaction with hosts
M. Kato-Maeda (2001)
10.1021/PR0499693
Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine.
A. Weston (2004)
10.1016/S0009-3084(02)00160-3
Gene expression profiling: methodological challenges, results, and prospects for addiction research.
J. Pollock (2002)
10.1517/14712598.3.4.655
Nanotechnology and medicine
D. Emerich (2003)
10.1002/PMIC.200300595
Methods and applications of antibody microarrays in cancer research
B. Haab (2003)
10.1002/RMV.328
Post‐genomic virology: the impact of bioinformatics, microarrays and proteomics on investigating host and pathogen interactions
P. Kellam (2001)
10.1002/PMIC.200390007
Protein arrays: The current state‐of‐the‐art
P. Cutler (2003)
10.1021/AC035048K
Glucose biosensor based on the microcantilever.
J. Pei (2004)
10.1111/1541-0420.T01-1-00027
Variances Are Not Always Nuisance Parameters
R. Carroll (2003)
10.1016/S0168-1656(02)00137-2
Bioinformatics methods for the analysis of expression arrays: data clustering and information extraction.
J. Tamames (2002)
10.1016/S0161-813X(02)00193-6
Use of microarray technologies in toxicology research.
K. Vrana (2003)
10.1016/S0958-1669(03)00068-5
Nanotechnology: convergence with modern biology and medicine.
M. Roco (2003)
10.1111/J.0006-341X.2002.00701.X
DNA microarray experiments: biological and technological aspects.
D. Nguyen (2002)
10.14219/JADA.ARCHIVE.2003.0195
Microarrays and clinical dentistry.
W. Kuo (2003)
10.1200/JCO.2002.12.073
Microarrays as cancer keys: an array of possibilities.
S. Mohr (2002)
10.1016/S0167-7799(03)00027-1
One step further towards real high throughput functional genomics
F. Michiels (2003)
10.1097/00041552-200307000-00009
DNA expression analysis: serial analysis of gene expression, microarrays and kidney disease
Patrick S Hayden (2003)
10.1002/PMIC.200300600
Protein microarrays: Promising tools for proteomic research
M. Templin (2003)
10.2144/03354SS03
Nucleic acid approaches for detection and identification of biological warfare and infectious disease agents.
D. Ivnitski (2003)
10.1023/A:1023025506386
Profiling Breast Cancer by Array CGH
D. Albertson (2004)
10.1146/ANNUREV.GENOM.3.031302.100922
Developmental genomic approaches in model organisms.
V. Reinke (2002)
10.1161/01.RES.0000036019.55901.62
DNA microarrays: implications for cardiovascular medicine.
S. Cook (2002)
10.1039/B300617D
Fluorescence-based fibre optic arrays: a universal platform for sensing.
J. Epstein (2003)
10.1081/AL-120018234
The Development of Novel Miniaturized Immuno-sensing Devices: A Review of a Small Technology with a Large Future
A. D. Sheehan (2003)
10.1002/ANGE.19280414804
Zur Internationalen Automobil‐ und Motorrad‐Ausstellung in Berlin
H. Bausch (1928)
10.1021/AC034031Z
Enantioselective sensors based on antibody-mediated nanomechanics.
P. Dutta (2003)
10.1016/S1369-5274(02)00280-1
Functional and comparative genomics of pathogenic bacteria.
G. Schoolnik (2002)
10.1016/S1535-6108(02)00242-8
Proteomics in translational cancer research: toward an integrated approach.
J. Celis (2003)
10.1002/cfg.320
Use of Complex DNA and Antibody Microarrays as Tools in Functional Analyses
A. Bauer (2003)
10.18388/ABP.2001_3896
An introduction to DNA chips: principles, technology, applications and analysis.
M. Gabig (2001)
10.1093/HMG/DDG053
DNA microarrays and development.
L. Smith (2003)
10.1046/J.0028-646X.2001.00303.X
Functional genomics: tools of the trade
Gillian Colebatch (2002)
10.1016/S0301-0082(03)00102-3
Thinking globally, acting locally: steroid hormone regulation of the dendritic architecture, synaptic connectivity and death of an individual neuron
J. Weeks (2003)
10.1152/AJPCELL.00397.2003
Drug discovery in academia.
A. Verkman (2004)
10.1016/S1471-4892(02)00202-3
Protein sequence analysis in silico: application of structure-based bioinformatics to genomic initiatives.
D. Michalovich (2002)
10.1016/S0163-7258(03)00086-X
cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease.
Eric R Marcotte (2003)
10.1016/S1471-4922(01)02153-5
DNA microarrays for malaria.
P. Rathod (2002)
10.1038/nrd1254
Tissue microarrays in drug discovery
G. Sauter (2003)
10.1043/1543-2165(2003)127<1089:GTPAN>2.0.CO;2
Genomics, transcriptomics, proteomics, and numbers.
F. Kiechle (2003)
10.1016/S0303-7207(02)00063-1
DNA microarrays for assessing ovarian cancer gene expression
I. Haviv (2002)
Choosing a company logo
A. Harding (2004)
10.1021/CM010578N
Colloidal Silica Films for High-Capacity DNA Probe Arrays
M. Glazer (2001)
10.1016/S1473-3099(04)00930-2
Chips with everything: DNA microarrays in infectious diseases.
P. Bryant (2004)
10.1159/000049904
Applications for Microarrays in Renal Biology and Medicine
E. Böttinger (2002)
10.1146/ANNUREV.BIOENG.5.011303.120723
Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics.
J. West (2003)
10.1016/S1471-1931(02)00201-X
Affinity-capture reagents for protein arrays.
G. Elia (2002)
10.1016/J.NUT.2003.08.001
A design and statistical perspective on microarray gene expression studies in nutrition: the need for playful creativity and scientific hard-mindedness.
G. Page (2003)
10.1038/nbt767
Long-term multiple color imaging of live cells using quantum dot bioconjugates
Jyoti K. Jaiswal (2003)
10.1016/j.tins.2003.08.004
Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays
F. Bareyre (2003)
10.1016/J.YMGME.2003.09.012
Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics.
P. Devarajan (2003)
10.2144/00295RV01
Fundamentals of DNA hybridization arrays for gene expression analysis.
W. Freeman (2000)
10.1002/GEPI.216
Microarrays and genetic epidemiology: A multipurpose tool for a multifaceted field
Dennise D Dalma-Weiszhausz (2002)
10.1002/dmrr.331
Gene expression profiling in islet biology and diabetes research
E. Bernal-Mizrachi (2003)
10.2144/03352RV01
Epigenomic profiling using microarrays.
B. van Steensel (2003)
10.1097/00125480-200101000-00002
Tissue Microarrays: What Will They Bring to Molecular and Anatomic Pathology?
H. Moch (2001)
10.1006/nbdi.2001.0387
Microarray Applications in Neuroscience
Z. Luo (2001)
10.1016/S1368-8375(02)00013-1
Gene expression profiling by DNA microarrays and its application to dental research.
W. Kuo (2002)
10.1080/09537329008524011
Cutting-edge technology
C. Turner (1990)
10.1021/bp020143k
Integration of Cell Culture and Microfabrication Technology
T. Park (2003)
Techview: molecular biology. Bead-based fiber-optic arrays.
D. Walt (2000)
10.1002/1521-3773(20020415)41:8<1276::AID-ANIE1276>3.0.CO;2-2
How to make a DNA chip.
M. Pirrung (2002)
10.1016/S1359-6446(02)02413-3
Antibody arrays: an embryonic but rapidly growing technology.
S. Lal (2002)
10.1016/S1368-8375(01)00041-0
Prognostic role of p27(Kip1) expression in oral squamous cell carcinoma in Taiwan.
M. Kuo (2002)
10.1126/SCIENCE.1067172
Protein Nanoarrays Generated By Dip-Pen Nanolithography
K. Lee (2002)
10.1016/J.CBPA.2003.07.001
Microscale separation and analysis.
J. Khandurina (2003)
10.1016/S1359-6446(02)02423-6
In need of high-throughput behavioral systems.
Dani Brunner (2002)
Fundamentals of DNA-chip/array technology for comparative gene-expression analysis
H. P. Saluz (2002)
10.1046/J.1525-1438.2002.01200.X
Proteomics in cancer research
W. Wu (2002)
10.1016/S0956-5663(03)00021-6
High-density, microsphere-based fiber optic DNA microarrays.
J. Epstein (2003)
10.1038/35087138
Navigating gene expression using microarrays — a technology review
Almut Schulze (2001)
10.1016/j.jcv.2003.08.002
A role for arrays in clinical virology: fact or fiction?
J. Clewley (2004)
10.1038/424610a
DNA microarrays: Vital statistics
Claire Tilstone (2003)
10.1517/14622416.3.5.589
Microarrays in pharmacogenomics--advances and future promise.
M. E. Chicurel (2002)
10.1016/S1357-4310(00)01815-3
Mining bacterial genomes for antimicrobial targets.
H. Loferer (2000)
10.1016/S0167-7799(03)00029-5
One step further towards real high-throughput functional genomics
R. O. Elferink (2003)
10.1016/S0531-5565(01)00231-5
Gene transcript profiling in aging research
S. Welle (2002)
10.1016/S1359-6446(02)02440-6
From microarrays to networks: mining expression time series.
T. Dewey (2002)
10.1016/S0168-1656(00)00363-1
Applied genome research in the field of human vaccines.
F. Berthet (2001)
10.1067/mhn.2002.127383
DNA Microarrays in Otolaryngology-Head and Neck Surgery
M. Whipple (2002)
10.1016/J.ACTATROPICA.2003.11.009
Microfluidic approaches to malaria detection.
P. Gascoyne (2004)
10.1023/A:1025166706481
Differential Gene Expression Analysis by DNA Microarray Technology and Its Application in Molecular Oncology
A. Frolov (2004)
10.1002/1521-3773(20021004)41:19<3583::AID-ANIE3583>3.0.CO;2-P
Carbohydrate arrays as tools for glycomics.
K. Love (2002)
10.1016/S1359-6446(02)02388-7
High-throughput cell analysis using multiplexed array technologies.
O. E. Beske (2002)
10.1002/PMIC.200300597
Light directed massively parallel on‐chip synthesis of peptide arrays with t‐Boc chemistry
X. Gao (2003)
10.1002/jcb.10408
Chemical microarrays, fragment diversity, label‐free imaging by plasmon resonance—a chemical genomics approach
D. Vetter (2002)
10.1146/ANNUREV.BIOENG.4.020702.153438
DNA microarray technology: devices, systems, and applications.
M. Heller (2002)
10.1093/CHEMSE/27.3.299
DNA microarray analysis of the aging brain.
T. Prolla (2002)
10.1007/s00277-003-0649-6
DNA microarray analysis in malignant lymphomas
C. Schwaenen (2003)
10.1358/DNP.2003.16.4.829333
Application of toxicogenomics in drug development.
T. Gant (2003)
10.1097/01.ASN.0000078035.81397.8A
Genomic strategies for diabetic nephropathy.
K. Suszták (2003)
10.1081/AL-120026566
DNA Microarray Applications in Environmental Microbiology
J. Letowski (2003)
10.1176/APPI.AJP.160.4.657
Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders.
W. Bunney (2003)
10.1016/S1359-6446(03)02779-X
G protein-coupled receptor microarrays for drug discovery.
Y. Fang (2004)
10.1016/S1369-5274(00)00093-X
Protein arrays for gene expression and molecular interaction screening.
G. Walter (2000)
10.1016/S1359-6446(02)02389-9
The impact of protein biochips and microarrays on the drug development process.
C. Huels (2002)
10.1016/S0887-2333(03)00121-8
Endocrine disruptors: effects on male fertility and screening tools for their assessment.
F. Eertmans (2003)
10.1097/00002281-200303000-00005
Genetic epidemiology: disease susceptibility and severity.
S. Steer (2003)
10.1016/S0006-2952(01)00785-7
Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.
P. Clarke (2001)
10.1016/S1369-5274(02)00327-2
Recent developments in DNA microarrays.
D. D. Shoemaker (2002)
10.1016/S0959-4388(02)90328-4
Streptococcus pneumoniae as a genomics platform for broad-spectrum antibiotic discovery.
J. Glass (2002)
10.1016/S1471-4914(02)02352-3
High-throughput protein arrays: prospects for molecular diagnostics.
G. Walter (2002)
10.1016/S1359-6446(01)02140-7
Cellular platforms for HTS: three case studies.
P. A. Johnston (2002)
10.1146/ANNUREV.PHARMTOX.40.1.177
Drug discovery in the next millennium.
E. Ohlstein (2000)
10.1016/S0092-8674(00)00005-2
Biomedical Discovery with DNA Arrays
R. Young (2000)
10.1111/j.1365-2559.2004.01766.x
Applications of microarrays to histopathology
M. van de Rijn (2004)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar